Última Hora: "Oito crianças mortas devido a queda de móveis do Ikea fazem loja reenviar alerta - Observador" Wed, 22 Nov 2017 12:03:23 GMT    "Costa acredita que Bruxelas vai ganhar "tranquilidade" com OE2018 - RTP" Wed, 22 Nov 2017 14:34:55 GMT    "Grande Reportagem: Inaugurado Évora Plaza, a ?nova centralidade? da cidade (c/som e fotos) - Rádio Campanário" Wed, 22 Nov 2017 12:05:57 GMT    "Alexandre Fonseca é o novo CEO da Portugal Telecom - Exame Informática" Wed, 22 Nov 2017 09:54:18 GMT    "Lisboa vai ter três novas rotas para Itália - Revista Sábado" Wed, 22 Nov 2017 15:29:28 GMT    "Prévia do Black Friday impulsiona comércio na capital - O Imparcial" Wed, 22 Nov 2017 14:12:31 GMT    "Sky abre mais 40 vagas de emprego em Portugal - Pplware" Wed, 22 Nov 2017 13:34:20 GMT    "Uber abafou ataque informático e subornou hackers para eliminar dados - RTP" Wed, 22 Nov 2017 10:38:00 GMT    "Comissão avisa para grande desigualdade salarial e para riscos do salário mínimo - Jornal de Negócios - Portugal" Wed, 22 Nov 2017 14:43:00 GMT   "This RSS feed URL is deprecated" Wed, 22 Nov 2017 16:31:59 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
Prior to joining Dyax, Todd was at Sunovion Pharmaceuticals, Inc. (previously Sepracor Inc., prior to its acquisition by Sumitomo Dainippon Pharma Co., Ltd), where he served in several roles of increasing responsibility including Vice President ...

e mais »

An Overview of Obsessive-Compulsive Disorder and Related Conditions: November 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


Directorate Change
London South East (blog)
... a member of the Board, at Vectura Group plc. Prior to this, he served as Chief Executive Officer and Chief Operating Officer at Critical Therapeutics Inc. and has also held senior management positions at Sepracor, Inc. (now Sunovion Pharmaceuticals ...


TechnoPOW (blog)

Desloratadine Market Healthcare, Clinical Reviews, Survey Reports 2017 to 2022
TechnoPOW (blog)
Leading Manufacturers Analysis in Global Desloratadine Market 2017: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt. The Global Desloratadine ...

e mais »

Pulmatrix (PULM) Appoints Dr. James Roach as CMO
StreetInsider.com
Pulmatrix, Inc. (NASDAQ: PULM), today announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new Chief Medical Officer, effective November 3, 2017. Dr. Roach will lead the clinical ... Prior to joining Veristat, he served as Senior ...

e mais »

Flex Pharma Reports Third Quarter 2017 Financial Results
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity associated with severe neurological diseases such as ...

e mais »

Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated Financials
PR Newswire (press release)
Prior to joining Veristat, he served as Senior Vice President, Development and Chief Medical Officer of Momenta Pharmaceuticals, Senior Vice President, Medical Affairs at Sepracor Pharmaceuticals, and Head of Medical Affairs at Millennium ...


Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
From 2007-2010, Mr. Koven served as Executive Vice President, General Counsel and Corporate Secretary at Sepracor Inc., where he was responsible for the company's legal and government affairs departments and Corporate Secretarial function until its ...

e mais »

Newshawk Time

Asthma Medication Market 2017: Global Industry Analysis, Top Company, Research Forecast, Analysis and Supply ...
Newshawk Time
Inc,AstraZeneca plc,Roche Holdings Ltd,Genentech Inc,Sepracor, Inc,Schering-Plough Corp,Sanofi-Aventis,Theravance Inc and many more. Global Asthma Medication market report also presents the manufacturers landscape and a corresponding detailed ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
Prior to HeartWare, Ms. Trevvett served in communications and investor relations roles at both Alkermes, Inc., a global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases, and Sepracor, ...

e mais »

Novelion Therapeutics Appoints Mark Corrigan, MD to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Prior to that, he was executive vice president, research & development of Sepracor Inc. (now Sunovion Pharmaceuticals). Prior to joining Sepracor, Dr. Corrigan spent 10 ...

e mais »

Desloratadine Sales Market Synthesis Healthcare, Clinical Reviews Reports 2017 to 2022
Equity Insider (press release)
These stakeholders include: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with severe neurological diseases, today announced the appointment of William K. McVicar, Ph.D., as President of Research and Development. ... ?With ...

e mais »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters